{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:52:09Z","timestamp":1790614329368,"version":"4.1.0"},"reference-count":35,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,4,19]],"date-time":"2007-04-19T00:00:00Z","timestamp":1176940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2007,5]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>ZAP\u201070 (zeta\u2010chain\u2010associated protein 70\u2003kDa) expression is associated with poor prognosis in patients with chronic lymphocytic leukaemia (CLL). This study evaluated the efficacy of non\u2010myeloablative allogeneic stem cell transplantation in patients with advanced CLL and assessed the impact of ZAP\u201070 expression on the outcome. Thirty\u2010nine sequential patients were included. All had previously been treated with fludarabine. All patients received a preparative regimen of fludarabine (30\u2003mg\/m<jats:sup>2<\/jats:sup>\/d for 3\u2003d), intravenous cyclophosphamide (750\u2003mg\/m<jats:sup>2<\/jats:sup>\/d for 3\u2003d), and high\u2010dose rituximab. Immunohistochemical techniques on marrow biopsy samples were used to determine that ZAP\u201070 was expressed in 25 patients, whereas 13 other patients were ZAP\u201070 negative, and one was of indeterminate status. With a median follow\u2010up time of 27\u2003months, the estimated overall survival and current progression\u2010free survival (CPFS) rates at 4\u2003years were 48% and 44% respectively. Patients who were ZAP\u201070 positive had 56% survival, and their CPFS rate increased from 30% to 53% after a donor lymphocyte infusion. Multivariate analysis indicated that chemorefractory disease and mixed T cell chimerism at day 90, but not ZAP\u201070 positivity, were associated with the risk of disease progression after transplantation. These results demonstrate a potent graft\u2010<jats:italic>versus<\/jats:italic>\u2010leukaemia effect that can overcome the adverse prognostic effect of ZAP\u201070 expression.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2007.06591.x","type":"journal-article","created":{"date-parts":[[2007,5,3]],"date-time":"2007-05-03T18:54:07Z","timestamp":1178218447000},"page":"355-363","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Graft\u2010<i>versus<\/i>\u2010leukaemia effect after non\u2010myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP\u201070 in refractory chronic lymphocytic leukaemia"],"prefix":"10.1111","volume":"137","author":[{"given":"Issa F.","family":"Khouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima M.","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Admirand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming\u2010S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Korbling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry I.","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De Marcos","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Champlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Bueso\u2010Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,4,19]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800145"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0941"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1683"},{"key":"e_1_2_5_5_1","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","article-title":"National Cancer Institute\u2010Sponsored Working Guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment","volume":"87","author":"Cheson B.D.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/74704"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2003.10.006"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa023143"},{"key":"e_1_2_5_9_1","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD 38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle R.N.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402905"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402036"},{"key":"e_1_2_5_12_1","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V (H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin T.J.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-200211000-00002"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704593"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3595"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2003.09.021"},{"key":"e_1_2_5_18_1","doi-asserted-by":"crossref","first-page":"19a","DOI":"10.1182\/blood.V106.11.48.48","article-title":"Autologous stem cell (AUTO) vs non\u2010 myeloablative allogeneic transplantation (NMT) after high\u2010dose rituximab (HD\u2010R) \u2010containing regimens for relapsed chemosensitive follicular lymphoma (FL)","volume":"106","author":"Khouri I.F.","year":"2005","journal-title":"Blood"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01982.x"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050642"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-02-0819"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.531"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-1105"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.8.2165"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15260-9"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705014"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.2307\/2530374"},{"key":"e_1_2_5_28_1","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka D.","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040857"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4321"},{"key":"e_1_2_5_31_1","first-page":"669","article-title":"Graft\u2010versus\u2010leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia","volume":"18","author":"Rondon G.","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.11.1639"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.12.011"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2281"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.569"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3306"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2007.06591.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2007.06591.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:49:18Z","timestamp":1697442558000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2007.06591.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,19]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["10.1111\/j.1365-2141.2007.06591.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06591.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,19]]},"assertion":[{"value":"2007-04-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}